¼ºñ½º »óǰ
¸®¼Ä¡ Á¤º¸
°í°´¼¾ÅÍ
°øÁö»çÇ×
´Ù¿î·Îµå
Financial
Information
e-Bond
Revolution
Market
Transparency
BONDWEB ½Ã½ºÅÛÀº ²÷ÀÓ¾ø´Â Á¤º¸Çõ½ÅÀ» ÅëÇØ ±ÝÀ¶ ¼±ÁøÈ¿¡ ±â¿©ÇÕ´Ï´Ù.
BONDWEB
º»µåÀ¥Plus
ÃֱٰԽù°
°æÁ¦Á¾ÇÕ´º½º
º¸µµÀÚ·á
½Ã°¡Æò°¡Ç¥
ÁÖ¿ä±Ý¸®
IRS/CRS
½ºÅ©·¦
ÇïÇÁµ¥½ºÅ©
´Ù¿î·Îµå¼¾ÅÍ
°øÁö»çÇ× & ´º½º
ÀÎÀçã±â
ENG
ÀÏÀÚ
ÆÄÀÏ
Á¦¸ñ
±â°ü¸í
04-17
[JAEMINI] ÀϺ» À帶°¨ ½ÃȲ 26.04.17
´ë½ÅÁõ±Ç
04-17
[ÇÑÈÅõÀÚÁõ±Ç ¹ÚÁ¦ÀÎ][¹Ì±¹ÁÖ½Ä] Abbott Laboratories (ABT) ÀÎ..
ÇÑÈÅõÀÚÁõ±Ç
04-17
[Ű¿ò ±Û·Î¹ú¸®¼Ä¡ÆÀ] Ű¿ò ±Û·Î¹ú ŰÂ÷Æ®(4¿ù 3ÁÖ)
Ű¿òÁõ±Ç
04-17
[Ű¿ò ¹Ì±¹ÁÖ½Ä ¹Ú±âÇö] ·¹µå¿ÍÀ̾î (RDW.US): ¿ìÁÖ ÀÎÇÁ¶ó´Â ³ª..
Ű¿òÁõ±Ç
04-17
[Ű¿ò ±Û·Î¹ú¸®¼Ä¡ÆÀ ±èÁø¿µ/Á¶È£ÁØ] ºí·¢½ºÄ«ÀÌ (BKSY.US): Ãà..
Ű¿òÁõ±Ç
04-17
±¹³» ÅõÀÚÀ¯¸Á Æ÷Æ®Æú¸®¿À
Çϳª±ÝÀ¶ÅõÀÚ
04-17
[IBKÅõÀÚÁõ±Ç ³²¼ºÇö] [À̸¶Æ®] ¹«³ÇÑ ½ÇÀû
IBKÅõÀÚÁõ±Ç
04-17
(¹Ì·¡¿¡¼ÂÁõ±Ç ±è¼®È¯) Çѱ¹ ¸¶ÄÏ Å¬·Î¡(4¿ù 17ÀÏ) : ¼û °í¸£±â..
¹Ì·¡¿¡¼Â´ë¿ì
04-17
[LS Á¤¿ì¼º ¹ÝµµÃ¼] SKÇÏÀ̴нº(000660): ¸Þ¸ð¸® ÇùÁÖ°î, Ä«µ§Â÷..
LSÁõ±Ç
04-17
[Market Analyst ÀÌÀç¿ø] ±¹³»ÁÖ½Ä ¸¶°¨ ½ÃȲ (26.04.17) - 3°Å·¡..
À¯¾ÈŸÁõ±Ç
04-17
NICEÇǾؾÆÀÌ - ä±Ç½ÃÀå Weekly(20260417)
NICEÇǾؾÆÀÌ
04-17
[À¯Áø/½º¸ôĸ/¹ÚÁ¾¼±]ºñ»óÀå±â¾÷ ÅõÀÚµ¿Çâ(2026-04)
À¯ÁøÅõÀÚÁõ±Ç
04-17
[JAEMINI]¹Ì±¹ À帶°¨ ½ÃȲ 26.04.17
´ë½ÅÁõ±Ç
04-17
[Weekly Issue] Daishins View
´ë½ÅÁõ±Ç
04-17
(¹Ì·¡¿¡¼ÂÁõ±Ç ±èÃæÇö, CFA) ¾Öº¸Æ® ·¡º¸·¯Å丮 (ABT US/Not Rat..
¹Ì·¡¿¡¼Â´ë¿ì
Àüü : 352
óÀ½
ÀÌÀü
[1]
[2]
[3]
[4]
[5]
´ÙÀ½
³¡À¸·Î
Ȩ > ¸®¼Ä¡Á¤º¸ >
ÃֱٰԽù°